Malawi National HIV & AIDS Monitoring and Evaluation Framework 2015-2020

Malawi’s rapid and successful Antiretroviral Therapy (ARV) scale-up from 2004 to 2014 has critically influenced the HIV epidemic, reducing mortality, morbidity, and transmission. In the one decade since starting the national treatment program:

• 1 out of every 20 Malawi adults are now on ART
• 275,000 deaths have been averted
• 1.4 million life-years have been gained, primarily among young adults in their peak productive life period.

In 2011, Malawi started implementing Prevention of Mother to Child Transmission (PMTCT) Option B+ policy , making life-long ART available for all HIV infected pregnant and breastfeeding women, regardless of clinical stage or CD4 count. This resulted in a 66% reduction of vertical transmission within 3 years. This Malawi-pioneered strategy has since then been included in global guidance by World Health Organisation (WHO). As of February 2014, 12 other African countries were implementing Option B+.